Literature DB >> 16175355

Neuropathologic characteristics of spinal cord lesions in sporadic Creutzfeldt-Jakob disease.

Yasushi Iwasaki1, Mari Yoshida, Yoshio Hashizume, Tetsuyuki Kitamoto, Gen Sobue.   

Abstract

We investigated the neuropathologic features of spinal cord lesions in 23 patients with sporadic Creutzfeldt-Jakob disease (sCJD), paying particular attention to neuronal loss and gliosis, pyramidal tract degeneration and prion protein (PrP) deposition. The study included 9 cases of subacute spongiform encephalopathy, 13 cases of panencephalopathic-type sCJD and 1 case of sporadic fatal insomnia (sFI). In the spinal gray matter, although gliosis was present in some patients with disease of relatively long duration, the number of neurons, including large motor neurons, was well preserved regardless of disease duration. Pyramidal tract degeneration was observed in some patients with disease lasting more than 14 months but not in the patient with sFI. PrP deposition was present in the spinal cord of all sCJD patients, and was identified predominantly in the posterior horn, particularly in the substantia gelatinosa, regardless of disease duration or disease classification based on cerebral pathology. Relatively prominent PrP deposition was also observed in Clarke's column. The density of PrP deposition in the sCJD spinal cord was not associated with disease duration or neuronal degeneration. Our results indicate that PrP deposition in the spinal cord is an early pathologic event in sCJD and may remain to the end stage. Although no VV1, VV2 or MV2 cases were included in our study, we suggest that stereotypic accumulation of PrP is a consistent pathologic feature of sCJD and that the spinal cord remains relatively resistant to the pathologic process of sCJD, at least in patients with MM1 sCJD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16175355     DOI: 10.1007/s00401-005-1076-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  7 in total

1.  Change in the characteristics of ferritin induces iron imbalance in prion disease affected brains.

Authors:  Ajay Singh; Liuting Qing; Qingzhong Kong; Neena Singh
Journal:  Neurobiol Dis       Date:  2011-12-11       Impact factor: 5.996

2.  Codistribution of amyloid beta plaques and spongiform degeneration in familial Creutzfeldt-Jakob disease with the E200K-129M haplotype.

Authors:  Nupur Ghoshal; Ignazio Cali; Richard Justin Perrin; S Andrew Josephson; Ning Sun; Pierluigi Gambetti; John Carl Morris
Journal:  Arch Neurol       Date:  2009-10

3.  Urodynamic findings in patients with Creutzfeldt-Jakob disease: a case report.

Authors:  Masashi Yano; Ryuji Sakakibara; Fuyuki Tateno; Osamu Takahashi; Haruka Nakamura; Megumi Sugiyama; Lee Fang-Ching; Syuichi Kamijima; Naoto Kamiya; Hiroyoshi Suzuki
Journal:  Int Urol Nephrol       Date:  2016-06-17       Impact factor: 2.370

4.  Creutzfeldt-Jakob disease with unusually extensive neuropathology in a child treated with native human growth hormone.

Authors:  Jacqueline Mikol; Jean-Philippe Deslys; Wen-Quan Zou; Wiangzhu Xiao; Paul Brown; Herbert Budka; Françoise Goutieres
Journal:  Clin Neuropathol       Date:  2012 May-Jun       Impact factor: 1.368

5.  Probable Creutzfeldt-Jakob Disease Presenting Dementia and Urinary Retention.

Authors:  Yosuke Aiba; Ryuji Sakakibara; Ayako Iimura; Chiaki Inoue; Keiichiro Terayama; Keiko Suzuki; Shuichi Katsuragawa; Fuyuki Tateno; Tsuyoshi Ogata
Journal:  Case Rep Neurol       Date:  2020-06-10

6.  Impaired axonal transport in motor neurons correlates with clinical prion disease.

Authors:  Vladimir Ermolayev; Toni Cathomen; Julia Merk; Mike Friedrich; Wolfgang Härtig; Gregory S Harms; Michael A Klein; Eckhard Flechsig
Journal:  PLoS Pathog       Date:  2009-08-21       Impact factor: 6.823

7.  System degeneration in an MM1-type sporadic Creutzfeldt-Jakob disease case with an unusually prolonged akinetic mutism state.

Authors:  Yasushi Iwasaki; Keiko Mori; Masumi Ito; Yoshinari Kawai; Akio Akagi; Yuichi Riku; Hiroaki Miyahara; Atsushi Kobayashi; Tetsuyuki Kitamoto; Mari Yoshida
Journal:  Prion       Date:  2021-12       Impact factor: 3.931

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.